KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Net Margin (2016 - 2025)

Gilead Sciences (GILD) has disclosed Net Margin for 17 consecutive years, with 31.9% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 836.0% year-over-year to 31.9%, compared with a TTM value of 30.08% through Dec 2025, up 2841.0%, and an annual FY2025 reading of 28.9%, up 2724.0% over the prior year.
  • Net Margin was 31.9% for Q4 2025 at Gilead Sciences, down from 39.27% in the prior quarter.
  • Across five years, Net Margin topped out at 39.27% in Q3 2025 and bottomed at 62.38% in Q1 2024.
  • Average Net Margin over 5 years is 17.91%, with a median of 22.66% recorded in 2022.
  • The sharpest move saw Net Margin skyrocketed 9158bps in 2021, then crashed -7788bps in 2024.
  • Year by year, Net Margin stood at 5.19% in 2021, then soared by 326bps to 22.1% in 2022, then decreased by -10bps to 19.9% in 2023, then grew by 18bps to 23.54% in 2024, then skyrocketed by 35bps to 31.9% in 2025.
  • Business Quant data shows Net Margin for GILD at 31.9% in Q4 2025, 39.27% in Q3 2025, and 27.69% in Q2 2025.